Status:
WITHDRAWN
Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Chronic Subdural Hematoma
Subdural Hematoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Subdural haematoma is a common neurosurgical condition that results in different levels of neurological deficits in patients. It can be further classified into acute and chronic, which have different ...
Detailed Description
The primary goal of the study is to assess the safety and efficacy of middle meningeal artery embolization in treating patients presenting with subdural haematoma. Previous studies and trial in other ...
Eligibility Criteria
Inclusion
- Patients (age 18 or above) with chronic subdural haematoma diagnosed by computed tomography and clinical presentation.
Exclusion
- SDH with thickness of 10mm or less, lack of mass effect.
- SDH secondary to existing conditions (brain tumour, arachnoid cyst, spontaneous intracranial hypotension, previous craniotomy not due to chronic SDH)
- Patients in poor medication condition or with life expectancy less than 6 months.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04500795
Start Date
January 1 2024
End Date
March 31 2027
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, The Chinese University of Hong Kong
Hong Kong, China